Delivery Order SPE2DR25D2009-SPE2DR26FJ3A0
- Not listed
- The Defense Logistics Agency awarded a $5,290.15 delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15 count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in supplying...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for Chloraseptic Max 15-10 mg lozenges (15-count packages) with a ceiling value of $1,800.03 and a completion date of October 20, 2025. This is a firm fixed price, non-set-aside contract executed as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract represents routine pharmaceutical supply fulfillment to support...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,707.30 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count packages). Issued on August 6, 2025, with an ultimate completion date of August 7, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,031.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Chloraseptic Max 15-10 mg lozenges. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max lozenges (15-10 mg, 15-count packages) with a ceiling value of $4,075.84 under a firm fixed-price contract type. The award was made on October 27, 2025, with an ultimate completion date of October 28, 2025. No set-aside designation was used in this competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- This contract award, valued at $2,241.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is a firm fixed price delivery order for the supply of pharmaceutical products, specifically Chloraseptic Max 15-10 mg lozenges, to support military treatment programs and facilities. The contract has an ultimate completion date of April 11, 2024. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.16 firm fixed-price delivery order is for CHLORASEPTIC MAX 15-10 MG LOZ 15S, a medical product. The contract has an ultimate completion date of March 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $3,452.36 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 19, 2025, for Chloraseptic Sore 18s products. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,825.86 firm-fixed-price delivery order is for "CHLORASEPTIC MAX 15-10 MG LOZ 15S", a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3A0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,385.94 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Chloraseptic Max 15-10 mg lozenges in quantities of 15 units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency and broader military healthcare systems through its comprehensive IDC vehicle. This delivery order exemplifies the company's role in supporting the supply chain for over-the-counter and pharmaceutical products to military and veteran healthcare programs. The DLA Troop Support Medical IDC represents a flexible contracting mechanism enabling the delivery of pharmaceutical commodities, medical supplies, and specialty medications across multiple therapeutic domains to support global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/12/25 |